Skip to main content

Advertisement

Table 1 Baseline patient characteristics

From: Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience

Variable Patients
Total 16
 Male 11
 Female 5
Age 63 (range 50 – 73)
Performance status  
 0 8
 1 8
Location of primary lesion  
 Head/Neck 8
 Body/Tail 8
Prior (concurrent) chemotherapy  
 Gemcitabine based 8
 5-FU based 5
 Both 3
Prior treatment  
 Pancreaticoduodenectomy 1
 SBRT 5
 DEBIRI-TACE 1
 Other 2
Median Total Bilirubin 0.6 (range 0.2 – 2.6)
Median Albumin 3.5 (range 2.2 – 4.4)
Median CA 19-9 15,836 (range 2 – 76587)
Hepatic tumor burden  
 <25 % 13
 25-50 % 3
Extra-hepatic disease  
 Lymph node 9
 Lung 3
 Peritoneal 3
 Other 1